Merck readies oral, macrocyclic PCSK9 inhibitor for phase II test
Abstract
No abstract.
Paper Details
Title
Merck readies oral, macrocyclic PCSK9 inhibitor for phase II test
Published Date
Nov 18, 2021
Volume
21
Issue
1
Pages
9 - 9
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History